Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Biomerieux Inc
WARNING LETTER
•Biomerieux Inc•July 30, 2014

Biomerieux Inc – FDA Warning Letter, Jul 30, 2014

Record Details

On July 14-30, 2014, an FDA inspection of BioMerieux SA's Hazelwood, MO facility revealed significant deviations from Quality System Regulations (21 CFR Part 820) for medical devices, rendering products adulterated.

Key violations include: 1. **Inadequate Complaint Handling (21 CFR 820.198(b)):** 18,926 complaints with component replacements lacked thorough investigation into failure causes (design, production, supply, assembly), and 6,861 complaints had no documented investigation or justification for not investigating. The firm's responses were deemed inadequate, failing to address retrospective analysis of component failures or adherence to their own complaint-handling procedures. 2. **Inadequate Control of Nonconforming Products (21 CFR 820.90(a)):** 39 production hardware failure non-conformances grouped different failure modes under one report, hindering trend analysis. The firm's response was inadequate, failing to address root cause investigation for these or the approximately 2,443 non-conformances since the last inspection. 3. **Inadequate CAPA Procedures (21 CFR 820.100(a)):** Complaint trending using undefined error codes and non-conformance trending by component instead of specific failure modes were inadequate. Responses were insufficient, with proposed corrective actions having excessively long

Company
Biomerieux Inc
Inspection date
July 30, 2014
Product type
Devices
Office
Kansas City District Office
People
  • Cheryl A. Bigham (Division Director)
  • Amy E. Devine
  • Antonio M. Santos
View Company Profile

ID · 27d2d192-fad8-42d8-b27e-1fb9fbd493af

Violation Codes10
21 CFR 82021 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 820.198(b)21 CFR 820.90(a)21 CFR 820.100(a)21 CFR 820.100(b)21 CFR 820.75(c)21 CFR 820.200(b)21 CFR 820.198(a)

Full citation text and observation details available on the Dashboard.

Other documents for Biomerieux Inc
  • 483 - 2019-08-20August 20, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Biomerieux Inc
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.